Skip to content
10-Q

Quarterly Report

SOMAXON PHARMACEUTICALS, INC.

0001193125-12-342309

← back to feed
Filed
Aug 8, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2012 · Jul 13, 2012 48.11M sh
Operating Cash Flow Q2 2012 · Jun 30, 2012 −$3.58M
Operating Cash Flow Q2 2012 · Jun 30, 2011 −$28.4M
Cash And Equivalents Q2 2012 · Jun 30, 2012 $7.08M
Cash And Equivalents Q2 2012 · Dec 31, 2011 $10.67M
Cash And Equivalents Q2 2012 · Jun 30, 2011 $28.4M
Cash And Equivalents Q2 2012 · Dec 31, 2010 $21.01M
Stockholders Equity Q2 2012 · Jun 30, 2012 $3.7M
Stockholders Equity Q2 2012 · Dec 31, 2011 $6.54M
Current Liabilities Q2 2012 · Jun 30, 2012 $7.62M
Current Liabilities Q2 2012 · Dec 31, 2011 $8.83M
Total Liabilities Q2 2012 · Jun 30, 2012 $8.24M
Total Liabilities Q2 2012 · Dec 31, 2011 $9.32M
Current Assets Q2 2012 · Jun 30, 2012 $10.23M
Current Assets Q2 2012 · Dec 31, 2011 $13.94M
Total Assets Q2 2012 · Jun 30, 2012 $11.94M
Total Assets Q2 2012 · Dec 31, 2011 $15.86M
Sga Expense Q2 2012 · Jun 30, 2012 $5.3M
Sga Expense Q2 2012 · Jun 30, 2012 $9.9M
Sga Expense Q2 2012 · Jun 30, 2011 $20.07M
Sga Expense Q2 2012 · Jun 30, 2011 $38.67M
Net Income Q2 2012 · Jun 30, 2012 −$2.2M
Net Income Q2 2012 · Jun 30, 2012 −$4.32M
Net Income Q2 2012 · Jun 30, 2011 −$14.95M
Net Income Q2 2012 · Jun 30, 2011 −$31.99M
Operating Income Q2 2012 · Jun 30, 2012 −$2.21M
Operating Income Q2 2012 · Jun 30, 2012 −$4.35M
Operating Income Q2 2012 · Jun 30, 2011 −$14.95M
Operating Income Q2 2012 · Jun 30, 2011 −$32M
Cost Of Revenue Q2 2012 · Jun 30, 2012 $265K
Cost Of Revenue Q2 2012 · Jun 30, 2012 $539K
Cost Of Revenue Q2 2012 · Jun 30, 2011 $661K
Cost Of Revenue Q2 2012 · Jun 30, 2011 $1.02M
Revenue Q2 2012 · Jun 30, 2012 $3.35M
Revenue Q2 2012 · Jun 30, 2012 $6.09M
Revenue Q2 2012 · Jun 30, 2011 $6.24M
Revenue Q2 2012 · Jun 30, 2011 $8.56M
Capex Q2 2012 · Jun 30, 2011 $318K
Rd Expense Q2 2012 · Jun 30, 2011 $457K
Rd Expense Q2 2012 · Jun 30, 2011 $876K